Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The combination of tadalafil and finasteride improves urinary symptoms and erectile function in men with enlarged prostates.

Finasteride may improve prostate cancer treatment outcomes.

Long-term treatment with finasteride or combined therapy worsens sexual function in men with urinary issues.

Combining oral minoxidil and bicalutamide may help improve hair growth in adolescent girls.

Alfatradiol (0.025%) is an effective and safe treatment for hair loss in both women and men.

GI197111X is best dissolved in Capmul MCM for trials.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Testosterone with dutasteride improves muscle strength and body composition in trans men.

Denosumab, a bone loss treatment, may cause hair loss and skin reactions due to immune system effects.

The new gel for hair loss is safe, effective, and reduces side effects.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Dutasteride effectively treats benign prostatic hyperplasia, improving symptoms and quality of life.

Dutasteride is approved to help manage prostate enlargement.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

A fast and accurate method was developed to measure alfuzosin and dutasteride in human plasma.

Dutasteride is becoming a popular hair loss treatment, proving more effective than finasteride with similar side effects.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

The new compound may be a safer alternative to finasteride for prostate protection.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Nanostructured lipid carriers can improve androgenic alopecia treatment by reducing dutasteride dosage and maintaining its presence in hair follicles longer.

A new, efficient method has been developed to detect darolutamide and thalidomide, drugs used for certain hair loss and prostate cancer treatments, in pharmaceuticals and body fluids.